Skip to Content

Haemonetics Corp HAE

Morningstar Rating
$73.21 −0.30 (0.41%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HAE is trading within a range we consider fairly valued.
Price
$72.98
Fair Value
$36.18
Uncertainty
Medium
1-Star Price
$49.27
5-Star Price
$85.42
Economic Moat
Tgfbskv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HAE is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$73.51
Day Range
$72.3074.07
52-Week Range
$70.7495.26
Bid/Ask
$29.29 / $117.13
Market Cap
$3.72 Bil
Volume/Avg
365,209 / 398,775

Key Statistics

Price/Earnings (Normalized)
18.50
Price/Sales
2.88
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
3,034

Competitors

Valuation

Metric
HAE
MDT
Price/Earnings (Normalized)
18.5015.47
Price/Book Value
3.842.16
Price/Sales
2.883.49
Price/Cash Flow
13.2215.06
Price/Earnings
HAE
MDT

Financial Strength

Metric
HAE
MDT
Quick Ratio
1.551.42
Current Ratio
2.922.29
Interest Coverage
18.678.96
Quick Ratio
HAE
MDT

Profitability

Metric
HAE
MDT
Return on Assets (Normalized)
9.86%7.71%
Return on Equity (Normalized)
22.91%13.75%
Return on Invested Capital (Normalized)
12.40%9.80%
Return on Assets
HAE
MDT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncTrsl$136.8 Bil
BDX
Becton Dickinson & CoBkmgth$69.8 Bil
ALC
Alcon IncWvnkkw$39.3 Bil
CLPBY
Coloplast A/S ADRKpwx$30.0 Bil
RMD
ResMed IncXxfqqh$27.0 Bil
WST
West Pharmaceutical Services IncDjw$26.6 Bil
BAX
Baxter International IncGrzhdl$21.3 Bil
COO
The Cooper Companies IncMzjcwyq$18.8 Bil
HOLX
Hologic IncZrtfwt$17.6 Bil
TFX
Teleflex IncXqfg$10.7 Bil

Sponsor Center